Cytosorbents (CTSO) Short-term Investments (2014 - 2024)

Cytosorbents' (CTSO) quarterly Short-term Investments came in at $5.0 million in Q4 2024, up 1908.03% quarter-over-quarter from $249000.0 in Q2 2016.

Analysis

Cytosorbents (CTSO) Short-term Investments (2014 - 2024) Analysis & Trends

Cytosorbents (CTSO) has reported Short-term Investments for 4 consecutive years, with $5.0 million the latest figure, recorded in Q4 2024.

For the quarter ending Q4 2024, Short-term Investments changed N/A year-over-year to $5.0 million; the trailing twelve-month figure through Dec 2024 stood at $5.0 million (changed N/A YoY), and the FY2024 full-year result was $5.0 million, changed N/A from the prior year.
Short-term Investments advanced to $5.0 million in Q4 2024 per CTSO's latest filing, from $249000.0 in the prior quarter.
Across five years, Short-term Investments topped out at $5.0 million in Q4 2024 and bottomed at $5.0 million in Q4 2024.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	183.04 Bn	177.44 Bn	7.27 Bn
2	Intuitive Surgical	125.02 Bn	119.81 Bn	1.96 Bn
3	Medtronic	117.84 Bn	109.02 Bn	6.34 Bn
4	Stryker	105.50 Bn	102.02 Bn	4.50 Bn
5	Boston Scientific	66.27 Bn	65.73 Bn	3.85 Bn
6	Edwards Lifesciences	49.60 Bn	45.35 Bn	1.35 Bn
7	Alcon	33.70 Bn	32.24 Bn	1.68 Bn
8	Dexcom	32.06 Bn	30.11 Bn	830.00 Mn
9	Steris	21.02 Bn	20.54 Bn	684.20 Mn
10	Cytosorbents	20.00 Mn	15.59 Mn	7.05 Mn

Historic Data

Download Data